Daejeon, South Korea

Hye Won Shin

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Daejeon, KR (2014 - 2019)
  • Gyeonggi-do, KR (2019 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Hye Won Shin: Innovator in Pharmaceutical Science

Introduction

Hye Won Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for neurological conditions. With a total of 10 patents to his name, his work continues to impact the medical community.

Latest Patents

Hye Won Shin's latest patents include innovative uses of carbamate compounds. One patent focuses on the use of a carbamate compound for the prevention, alleviation, or treatment of status epilepticus. This invention involves administering a medicament or pharmaceutical composition that contains a specific carbamate compound. Another patent addresses the prevention, alleviation, or treatment of myotonia, utilizing a carbamate compound or its pharmaceutically acceptable derivatives.

Career Highlights

Hye Won Shin is currently associated with SK Biopharmaceuticals Co., Ltd., a leading company in the pharmaceutical industry. His work at the company has been instrumental in advancing research and development in the field of neurology. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Hye Won Shin collaborates with talented professionals in his field, including Cheol Young Maeng and Young Koo Jang. These collaborations enhance the research efforts and contribute to the successful development of new pharmaceutical solutions.

Conclusion

Hye Won Shin's contributions to pharmaceutical science, particularly through his innovative patents, demonstrate his commitment to improving medical treatments. His work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…